Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes - Summary - MDSpire
Advertisement
Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes
To examine the association of CMV DNAemia with clinical outcomes in hospitalized adults with COVID-19 requiring oxygen support, specifically focusing on the implications of CMV reactivation.
Key Findings:
11% cumulative incidence of CMV DNAemia by day 28 among CMV-seropositive participants, highlighting a significant clinical concern.
CMV DNAemia associated with older age, male sex, lymphopenia, and corticosteroid use, indicating potential risk factors.
CMV DNAemia linked to lower probability of clinical improvement and higher SARS-CoV-2 viral load, suggesting a detrimental impact on recovery.
Increased mortality associated with CMV DNAemia, underscoring its importance in clinical outcomes.
Interpretation:
CMV viremia occurs in hospitalized COVID-19 patients and is independently linked to delayed recovery, higher viral loads, and increased mortality, emphasizing the need for monitoring CMV in this population.
Limitations:
Study limited to CMV-seropositive individuals, which may restrict the applicability of findings to the broader COVID-19 patient population.
Findings may not be generalizable to all COVID-19 patients, particularly those who are CMV-seronegative.
Conclusion:
CMV DNAemia is a significant factor affecting clinical outcomes in hospitalized adults with COVID-19 requiring oxygen support.
by Michael Boeckh, Hu Xie, Terry Stevens-Ayers, Linda Sircy, Danniel Zamora, Jason D Goldman, Christopher W Woods, Renee D Stapleton, Gordon Rubenfeld, Andre Kalil, Keith R Jerome, Sayan Dasgupta, Ajit P Limaye
